Berberine Improving Cognitive Impairments in Schizophrenia

NCT07359209 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia Therapeutics

Interventions

DRUG: Berberine
DRUG: Placebo

Sponsor

Tianjin Anding Hospital